Breaking News, Promotions & Moves

BBOT Appoints Uneek Mehra as Chief Financial Officer

Mehra is a seasoned financial executive with decades of financial knowledge across biotech and global healthcare.

By: Rachel Klemovitch

Assistant Editor

TheRas, Inc. d/b/a BBOT, a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, appointed Uneek Mehra as Chief Financial Officer. Mehra brings over 28 years of global financial and business leadership experience across the biotechnology and pharmaceutical industries. Mehra most recently served as Chief Financial & Business Officer at 4D Molecular Therapeutics (4DMT), where he led financing rounds and capital allocation efforts to ensure funding for two large Phase...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters